VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
72,296
AK1,638
AL5,339
AR3,412
AS44
AZ13,316
CA58,147
CO11,002
CT7,824
DC1,626
DE1,670
FL36,235
FM3
GA13,429
GU82
HI2,195
IA4,332
ID2,473
IL19,261
IN22,568
KS4,284
KY6,945
LA4,714
MA13,886
MD11,901
ME2,997
MH8
MI17,865
MN11,345
MO8,919
MP30
MS2,676
MT2,147
NC15,401
ND1,273
NE2,732
NH2,859
NJ17,232
NM3,702
NV4,071
NY32,763
OH18,072
OK5,940
OR7,954
PA22,457
PR2,104
QM2
RI1,911
SC6,055
SD1,133
TN8,691
TX34,122
UT4,023
VA13,944
VI49
VT1,661
WA13,811
WI10,395
WV2,220
WY805
XB5
XL1
XV2

ID: 1555306
Sex: M
Age: 76
State: TX

Vax Date: 01/25/2021
Onset Date: 01/26/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: bruise at the injection site; injection site was sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (bruise at the injection site) and VACCINATION SITE PAIN (injection site was sore) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The patient's past medical history included Kidney transplant (2 years ago). On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE BRUISING (bruise at the injection site) and VACCINATION SITE PAIN (injection site was sore). At the time of the report, VACCINATION SITE BRUISING (bruise at the injection site) had not resolved and VACCINATION SITE PAIN (injection site was sore) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1555307
Sex: M
Age:
State: MI

Vax Date: 01/28/2021
Onset Date: 02/12/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Patient tested positive for COVID 19; This spontaneous case was reported by a health care professional and describes the occurrence of COVID-19 (Patient tested positive for COVID 19) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history reported. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced COVID-19 (Patient tested positive for COVID 19). At the time of the report, COVID-19 (Patient tested positive for COVID 19) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Feb-2021, Coronavirus test: positive positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1555308
Sex: F
Age:
State: OH

Vax Date:
Onset Date: 02/23/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: resting heart rate did not go down to where it was before; headaches last night, much better today; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headaches last night, much better today) and HEART RATE INCREASED (resting heart rate did not go down to where it was before) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. No medical history reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced HEADACHE (headaches last night, much better today). On 24-Feb-2021, the patient experienced HEART RATE INCREASED (resting heart rate did not go down to where it was before). At the time of the report, HEADACHE (headaches last night, much better today) and HEART RATE INCREASED (resting heart rate did not go down to where it was before) outcome was unknown. Patient stated that her normal RHR is approximately 70 after doing exercise and her current reading is 96. Concomitant medications were not reported. Treatment information has not been specified.

Other Meds:

Current Illness:

ID: 1555309
Sex: M
Age: 83
State: VA

Vax Date: 01/23/2021
Onset Date: 01/23/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: daily headaches that last for an hour or two; Slight headache; Body temperature has not been really high but has been a little higher than normal (normally 97-98?F now 98-99.3?F); Pain in his body more than usual; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain in his body more than usual), HEADACHE (daily headaches that last for an hour or two), HEADACHE (Slight headache) and PYREXIA (Body temperature has not been really high but has been a little higher than normal (normally 97-98?F now 98-99.3?F)) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. Concurrent medical conditions included Pain. Concomitant products included HYDROCODONE for an unknown indication. On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced PAIN (Pain in his body more than usual), HEADACHE (Slight headache) and PYREXIA (Body temperature has not been really high but has been a little higher than normal (normally 97-98?F now 98-99.3?F)). On 27-Jan-2021, the patient experienced HEADACHE (daily headaches that last for an hour or two). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Adverse event following immunisation, at a dose of 2 pills. On 23-Jan-2021, HEADACHE (Slight headache) had resolved. At the time of the report, PAIN (Pain in his body more than usual), HEADACHE (daily headaches that last for an hour or two) and PYREXIA (Body temperature has not been really high but has been a little higher than normal (normally 97-98?F now 98-99.3?F)) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature (97-98): 98-99.3 (High) 98-99.3. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: ADR form received but incomplete and contained no new information.

Other Meds: HYDROCODONE

Current Illness: Pain

ID: 1555310
Sex: M
Age:
State: OK

Vax Date:
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Muscle stiffness; Chills; Fatigue; Headache; This spontaneous case was reported by an other health care professional and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Muscle stiffness), CHILLS (Chills), FATIGUE (Fatigue) and HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (Muscle stiffness), CHILLS (Chills), FATIGUE (Fatigue) and HEADACHE (Headache). At the time of the report, MUSCULOSKELETAL STIFFNESS (Muscle stiffness), CHILLS (Chills), FATIGUE (Fatigue) and HEADACHE (Headache) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1555311
Sex: F
Age: 28
State: WI

Vax Date: 01/22/2021
Onset Date: 01/23/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Soreness at the injection site; Swelling; Tingling; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at the injection site), SWELLING (Swelling) and PARAESTHESIA (Tingling) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. No medical history reported. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced VACCINATION SITE PAIN (Soreness at the injection site), SWELLING (Swelling) and PARAESTHESIA (Tingling). At the time of the report, VACCINATION SITE PAIN (Soreness at the injection site), SWELLING (Swelling) and PARAESTHESIA (Tingling) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1555312
Sex: F
Age: 56
State: IL

Vax Date: 02/23/2021
Onset Date: 02/23/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Back pain; Nausea; Painful headache; Dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), BACK PAIN (Back pain), NAUSEA (Nausea) and HEADACHE (Painful headache) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The patient's past medical history included COVID-19 in 2020. On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced DIZZINESS (Dizzy), NAUSEA (Nausea) and HEADACHE (Painful headache). On 24-Feb-2021, the patient experienced BACK PAIN (Back pain). The patient was treated with PARACETAMOL (TYLENOL) for Dizzy, Nausea, Headache and Back pain, at a dose of UNK dosage form and IBUPROFEN for Dizzy, Nausea, Headache and Back pain, at a dose of UNK dosage form. At the time of the report, DIZZINESS (Dizzy), BACK PAIN (Back pain), NAUSEA (Nausea) and HEADACHE (Painful headache) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not reported.

Other Meds:

Current Illness:

ID: 1555313
Sex: F
Age: 77
State:

Vax Date: 02/03/2021
Onset Date: 02/04/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: not able to keep anything down; extreme nausea; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (not able to keep anything down) and NAUSEA (extreme nausea) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION COMPLICATION (not able to keep anything down) and NAUSEA (extreme nausea). The patient was treated with GLUCOSE, POTASSIUM CITRATE, SODIUM CHLORIDE (PEDIALYTE 30) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (not able to keep anything down) and NAUSEA (extreme nausea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided. Lab details were not provided.

Other Meds:

Current Illness:

ID: 1555314
Sex: M
Age:
State: AL

Vax Date: 02/22/2021
Onset Date: 02/23/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: He has stayed in bed most of the time since yesterday at 2 pm; Very little appetite; Fever (99.5-100.5); Muscle ache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (He has stayed in bed most of the time since yesterday at 2 pm), DECREASED APPETITE (Very little appetite), PYREXIA (Fever (99.5-100.5)) and MYALGIA (Muscle ache) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042120A) for COVID-19 vaccination. No Medical History information was reported. On 22-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced VACCINATION COMPLICATION (He has stayed in bed most of the time since yesterday at 2 pm), DECREASED APPETITE (Very little appetite), PYREXIA (Fever (99.5-100.5)) and MYALGIA (Muscle ache). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at a dose of UNK dosage form. At the time of the report, VACCINATION COMPLICATION (He has stayed in bed most of the time since yesterday at 2 pm), DECREASED APPETITE (Very little appetite), PYREXIA (Fever (99.5-100.5)) and MYALGIA (Muscle ache) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Feb-2021, Body temperature: 99.5-100.5 (High) 99.5-100.5. On 24-Feb-2021, Body temperature: 99.5 (High) in the morning. Concomitant medication was not included. The patient took Tylenol which helped a little bit but it was not a game changer.

Other Meds:

Current Illness:

ID: 1555315
Sex: F
Age: 65
State: FL

Vax Date: 02/06/2021
Onset Date: 02/07/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Arm Pain; Swollen Lymph Nodes; Fever - Temperature as high as 101.0F; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm Pain), LYMPHADENOPATHY (Swollen Lymph Nodes), PYREXIA (Fever - Temperature as high as 101.0F) and FATIGUE (Fatigue) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. No Medical History information was reported. On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm Pain), LYMPHADENOPATHY (Swollen Lymph Nodes), PYREXIA (Fever - Temperature as high as 101.0F) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL) for Swollen lymph nodes, Pain in arm, Fever and Fatigue, at a dose of UNK dosage form and IBUPROFEN (ADVIL [IBUPROFEN]) for Swollen lymph nodes, Pain in arm, Fever and Fatigue, at a dose of UNK dosage form. At the time of the report, PAIN IN EXTREMITY (Arm Pain), LYMPHADENOPATHY (Swollen Lymph Nodes), PYREXIA (Fever - Temperature as high as 101.0F) and FATIGUE (Fatigue) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Feb-2021, Body temperature: 101.0 (High) 101.0 F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication was not reported.

Other Meds:

Current Illness:

ID: 1555316
Sex: M
Age:
State: KS

Vax Date: 02/23/2021
Onset Date: 02/01/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Body ache; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body ache) and HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced MYALGIA (Body ache) and HEADACHE (Headache). At the time of the report, MYALGIA (Body ache) and HEADACHE (Headache) outcome was unknown. Concomitant medication was not reported. Treatment medication was not reported.

Other Meds:

Current Illness:

ID: 1555317
Sex: F
Age:
State: SC

Vax Date: 02/23/2021
Onset Date: 02/24/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tingling on a spot on lip; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ORAL (tingling on a spot on lip) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Blister of lip (getting blister on lip if while staying out in the sun without sunscreen.). On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced PARAESTHESIA ORAL (tingling on a spot on lip). At the time of the report, PARAESTHESIA ORAL (tingling on a spot on lip) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication was provided. No treatment details were provided.

Other Meds:

Current Illness:

ID: 1555318
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Stiffness of the arm of the injection; Fever; Body ache; Headache; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Stiffness of the arm of the injection), PYREXIA (Fever), PAIN (Body ache) and HEADACHE (Headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (Stiffness of the arm of the injection), PYREXIA (Fever), PAIN (Body ache) and HEADACHE (Headache). The patient was treated with TRAMADOL at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, LYMPHADENOPATHY (Stiffness of the arm of the injection), PYREXIA (Fever), PAIN (Body ache) and HEADACHE (Headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided.

Other Meds:

Current Illness:

ID: 1555319
Sex: F
Age: 67
State: FL

Vax Date: 02/14/2021
Onset Date: 02/01/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: her head is bothering her; pain in her arm for three days that made her shoulder hurt and even her lung; pain in lung; shoulder hurt; Mild headache; This spontaneous case was reported by a patient and describes the occurrence of SINUS HEADACHE (her head is bothering her), PAIN IN EXTREMITY (pain in her arm for three days that made her shoulder hurt and even her lung), PULMONARY PAIN (pain in lung), ARTHRALGIA (shoulder hurt) and HEADACHE (Mild headache) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. Concurrent medical conditions included Ear discomfort and Sinusitis. On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced PAIN IN EXTREMITY (pain in her arm for three days that made her shoulder hurt and even her lung), PULMONARY PAIN (pain in lung), ARTHRALGIA (shoulder hurt) and HEADACHE (Mild headache). On 24-Feb-2021, the patient experienced SINUS HEADACHE (her head is bothering her). In February 2021, PAIN IN EXTREMITY (pain in her arm for three days that made her shoulder hurt and even her lung) had resolved. At the time of the report, SINUS HEADACHE (her head is bothering her), PULMONARY PAIN (pain in lung), ARTHRALGIA (shoulder hurt) and HEADACHE (Mild headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. On 13-FEB-2021, the patient went to the physician because her ear was bothering her and was prescribed amoxicillin antibiotic. She did not take it because the next day she had to get the vaccinated. No treatment information was provided.

Other Meds:

Current Illness: Ear discomfort; Sinusitis

ID: 1555320
Sex: F
Age: 33
State: MO

Vax Date: 01/24/2021
Onset Date: 01/24/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pregnancy; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) in a 33-year-old female patient (gravida 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 006M20A) for COVID-19 vaccination. The patient's past medical history included In vitro fertilisation. Previously administered products included for an unreported indication: ALCOHOL (5 drinks/ week socially.) from 22-Dec-2008 to 01-Sep-2020. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) from 25-Aug-2020 to 17-May-2021, ACETYLSALICYLIC ACID (BABY ASPIRIN), PROGESTERONE from 13-Sep-2020 to 07-Nov-2020, ESTRADIOL (ESTROGEN) from 24-Aug-2020 to an unknown date, ESTRADIOL (ESTROGEN) from 04-Sep-2020 to an unknown date and OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]) from 08-Dec-2020 to an unknown date for an unknown indication. On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 01-Aug-2020 and the estimated date of delivery was 05-Jun-2021. On 24-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the twenty-fifth week of the pregnancy. On 24-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Sep-2020, Pregnancy test: Positive. On 19-Oct-2020, Ultrasound foetal: normal. On 24-Oct-2020, Ultrasound foetal: normal. On 25-Nov-2020, Prenatal screening test: normal. On 25-Nov-2020, Ultrasound foetal: normal. On 20-Jan-2021, Ultrasound foetal: normal. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Patient had a positive pregnancy test on 22 Sep 2020. Her last menstrual period was 1 Aug 2020 and estimated date of conception was 12 Sep 2020.Patient had a missed pregnancy on 12 Oct 2019. Patient's medical history include unexplained infertility , unsuccessful medicated / monitored aids followed by successful IVF. Family history include down syndrome for the father's sister. Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Patient demography , medical history , lab data and concomitant medications information were updated.

Other Meds: PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]; BABY ASPIRIN; PROGESTERONE; ESTROGEN; ESTROGEN; PRILOSEC [OMEPRAZOLE]

Current Illness:

ID: 1555321
Sex: F
Age: 92
State: OH

Vax Date: 01/19/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: FEVER; DIZZINESS; HE IS SO DIZZY THAT HE FELL AND HIT HEAD; dehydrated; Loss of taste; loss of smell; COULDN'T EAT NOR DRINK FOR SOME DAYS; CHILLS; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (CHILLS), PYREXIA (FEVER), DIZZINESS (DIZZINESS), FALL (HE IS SO DIZZY THAT HE FELL AND HIT HEAD) and DEHYDRATION (dehydrated) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient experienced CHILLS (CHILLS), PYREXIA (FEVER), DIZZINESS (DIZZINESS), FALL (HE IS SO DIZZY THAT HE FELL AND HIT HEAD), DEHYDRATION (dehydrated), AGEUSIA (Loss of taste), ANOSMIA (loss of smell) and DECREASED APPETITE (COULDN'T EAT NOR DRINK FOR SOME DAYS). The patient was treated with NORMAL SALINE at an unspecified dose and frequency and CALCIUM ASCORBATE, MAGNESIUM GLUCONATE, MAGNESIUM LACTATE, POTASSIUM CITRATE (ELECTROLYTE + C) at an unspecified dose and frequency. At the time of the report, CHILLS (CHILLS), PYREXIA (FEVER), DIZZINESS (DIZZINESS), FALL (HE IS SO DIZZY THAT HE FELL AND HIT HEAD), DEHYDRATION (dehydrated), AGEUSIA (Loss of taste), ANOSMIA (loss of smell) and DECREASED APPETITE (COULDN'T EAT NOR DRINK FOR SOME DAYS) outcome was unknown. This case was linked to MOD21-037815 (Patient Link).

Other Meds:

Current Illness:

ID: 1555322
Sex: F
Age:
State: SC

Vax Date: 01/29/2021
Onset Date: 01/29/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: injection site became hard; injection site was sore; Feverish; the injection site became red/it was still red 4 to 5 inches in diameter; injection site became swollen, and got worst by February 7th.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (injection site became hard), VACCINATION SITE ERYTHEMA (the injection site became red/it was still red 4 to 5 inches in diameter), VACCINATION SITE SWELLING (injection site became swollen, and got worst by February 7th.), VACCINATION SITE PAIN (injection site was sore) and PYREXIA (Feverish) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (the injection site became red/it was still red 4 to 5 inches in diameter) and VACCINATION SITE SWELLING (injection site became swollen, and got worst by February 7th.). On 07-Feb-2021, the patient experienced VACCINATION SITE INDURATION (injection site became hard), VACCINATION SITE PAIN (injection site was sore) and PYREXIA (Feverish). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 07-Feb-2021 for Vaccination site induration, Vaccination site erythema, Vaccination site swelling, Vaccination site pain and Feverish, at a dose of UNK dosage form and PARACETAMOL (TYLENOL EXTRA STRENGTH) for Vaccination site induration, Vaccination site erythema, Vaccination site swelling, Vaccination site pain and Feverish, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE INDURATION (injection site became hard), VACCINATION SITE ERYTHEMA (the injection site became red/it was still red 4 to 5 inches in diameter), VACCINATION SITE SWELLING (injection site became swollen, and got worst by February 7th.), VACCINATION SITE PAIN (injection site was sore) and PYREXIA (Feverish) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not reported. Treatment also included a prescription cream (topical) and it started to improve over night.

Other Meds:

Current Illness:

ID: 1555323
Sex: F
Age: 56
State: IL

Vax Date: 02/18/2021
Onset Date: 02/18/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: numbness in toes; minor weakness in legs; minor low back aches; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numbness in toes), MUSCULAR WEAKNESS (minor weakness in legs) and BACK PAIN (minor low back aches) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced HYPOAESTHESIA (numbness in toes), MUSCULAR WEAKNESS (minor weakness in legs) and BACK PAIN (minor low back aches). At the time of the report, HYPOAESTHESIA (numbness in toes), MUSCULAR WEAKNESS (minor weakness in legs) and BACK PAIN (minor low back aches) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication was provided. No treatment details were provided.

Other Meds:

Current Illness:

ID: 1555324
Sex: M
Age:
State:

Vax Date: 01/18/2021
Onset Date: 01/18/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: cellulitis; Pain; rash trunk; temperature of 99.5 degrees F; muscle pain; joint pain; massive lump on shoulder big as a grapefruit; itching really bad; Massive Headache; vaccination site erythema; A spontaneous report was received from a consumer, concerning a male patient of unknown age, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced cellulitis, itching really bad/injection site pruritus, muscle pain/myalgia, joint pain/arthralgia, massive great fruit sized lump/injection site lump, temperature of 99.5 degrees/pyrexia, and massive headache. The patient's medical history was not reported. No Relevant concomitant medications were reported like On 18JAN2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch:013L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection. On date 18JAN2021, The patient experienced a massive lump on shoulder big as a grapefruit, rash under his chest and arm, major red skin under the arm, temperature of 99.5 degrees F, muscle pain, joint pain, felt like shingles, burning skin, itching really bad, cellulitis, scalded. Laboratory details not provided. Treatment information was provided : cephalexin 500mg three times a day for 7 days lidocaine 5% ointment twice a day for 7 days triamcinolone acetate 0.5% twice a day if needed for 7 days naproxen 250 mg twice a day Action taken with mRNA-1273 in response to the events was not reported. The outcome of the events were all recovered.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1555325
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: itching from scalp to legs; tongue and lip swelled; tongue and lip swelled; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PRURITUS (itching from scalp to legs), SWOLLEN TONGUE (tongue and lip swelled) and LIP SWELLING (tongue and lip swelled) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itching from scalp to legs), SWOLLEN TONGUE (tongue and lip swelled) and LIP SWELLING (tongue and lip swelled). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itching all over, Tongue swelling non-specific and Lip swelling, at a dose of UNK dosage form. At the time of the report, PRURITUS (itching from scalp to legs), SWOLLEN TONGUE (tongue and lip swelled) and LIP SWELLING (tongue and lip swelled) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication was not reported. The physician reported that the itching from scalp to legs did not break out in a rash.

Other Meds:

Current Illness:

ID: 1555326
Sex: M
Age: 71
State: ID

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Warmness at the injection site; Hives at top torso; Headache; Nausea; Swelling at the injection site; Turned red at injection site; uncomfortable; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (uncomfortable), VACCINATION SITE WARMTH (Warmness at the injection site), URTICARIA (Hives at top torso), HEADACHE (Headache) and NAUSEA (Nausea) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced DISCOMFORT (uncomfortable). On 06-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Warmness at the injection site), URTICARIA (Hives at top torso), HEADACHE (Headache), NAUSEA (Nausea), VACCINATION SITE SWELLING (Swelling at the injection site) and VACCINATION SITE ERYTHEMA (Turned red at injection site). At the time of the report, DISCOMFORT (uncomfortable), VACCINATION SITE WARMTH (Warmness at the injection site), URTICARIA (Hives at top torso), HEADACHE (Headache), NAUSEA (Nausea), VACCINATION SITE SWELLING (Swelling at the injection site) and VACCINATION SITE ERYTHEMA (Turned red at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication was provided. No treatment details were provided.

Other Meds:

Current Illness:

ID: 1555327
Sex: M
Age: 71
State: AK

Vax Date: 02/23/2021
Onset Date: 02/24/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tender to the touch; swollen; hard; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swollen), VACCINATION SITE INDURATION (hard) and VACCINATION SITE PAIN (tender to the touch) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The patient's past medical history included Drug addiction. Concurrent medical conditions included Blood pressure. Concomitant products included LOSARTAN POTASSIUM (LOSARTAN [LOSARTAN POTASSIUM]) for Hypertension. On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On 24-Feb-2021, the patient experienced VACCINATION SITE SWELLING (swollen), VACCINATION SITE INDURATION (hard) and VACCINATION SITE PAIN (tender to the touch). At the time of the report, VACCINATION SITE SWELLING (swollen), VACCINATION SITE INDURATION (hard) and VACCINATION SITE PAIN (tender to the touch) outcome was unknown. No concomitant medication was provided. No treatment details were provided.

Other Meds: LOSARTAN [LOSARTAN POTASSIUM]

Current Illness: Blood pressure

ID: 1555328
Sex: F
Age: 85
State: CA

Vax Date: 01/28/2021
Onset Date: 02/24/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: can't drive because feels weak/weakness; can't drive because she feels dizzy/dizziness; tossing and turning and cannot sleep on her left side; nausea; chills; sore arm; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (can't drive because feels weak/weakness), DIZZINESS (can't drive because she feels dizzy/dizziness), INSOMNIA (tossing and turning and cannot sleep on her left side), NAUSEA (nausea) and CHILLS (chills) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 029L204) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Graves' disease. Concomitant products included VITAMINS NOS for an unknown indication. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced ASTHENIA (can't drive because feels weak/weakness), DIZZINESS (can't drive because she feels dizzy/dizziness), INSOMNIA (tossing and turning and cannot sleep on her left side), NAUSEA (nausea), CHILLS (chills), VACCINATION SITE PAIN (sore arm) and FATIGUE (fatigue). At the time of the report, ASTHENIA (can't drive because feels weak/weakness), DIZZINESS (can't drive because she feels dizzy/dizziness), INSOMNIA (tossing and turning and cannot sleep on her left side), NAUSEA (nausea), CHILLS (chills), VACCINATION SITE PAIN (sore arm) and FATIGUE (fatigue) outcome was unknown. Concomitant medication included thyroid pill every morning for Graves disease. The patient did not take any treatment medication. The patient usually was very healthy and active.

Other Meds: VITAMINS NOS

Current Illness: Graves' disease

ID: 1555329
Sex: F
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Injection site pain) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PAIN (Injection site pain). The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication was provided. No treatment details were provided.

Other Meds:

Current Illness:

ID: 1555330
Sex: F
Age: 73
State: GA

Vax Date: 01/01/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Hot at injection site; Redness at injection site; swollen at injection site; feverish (at injection site); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE SWELLING (swollen at injection site) and PYREXIA (feverish (at injection site)) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 01-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE SWELLING (swollen at injection site) and PYREXIA (feverish (at injection site)). At the time of the report, VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE SWELLING (swollen at injection site) and PYREXIA (feverish (at injection site)) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not reported. Treatment medication was not reported.

Other Meds:

Current Illness:

ID: 1555331
Sex: F
Age: 66
State:

Vax Date: 02/19/2021
Onset Date: 02/19/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: neck popping; ache neck and scull; dizziness; headache; fatigue; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (neck popping), PAIN (ache neck and scull), DIZZINESS (dizziness), HEADACHE (headache) and FATIGUE (fatigue) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Vertigo. On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 19-Feb-2021, the patient experienced DIZZINESS (dizziness), HEADACHE (headache), FATIGUE (fatigue) and VACCINATION SITE PAIN (Pain at injection site). On 21-Feb-2021, the patient experienced PAIN (ache neck and scull). On 23-Feb-2021, the patient experienced MUSCLE SPASMS (neck popping). On 21-Feb-2021, HEADACHE (headache) had resolved. On 23-Feb-2021, MUSCLE SPASMS (neck popping) had resolved. On 24-Feb-2021, FATIGUE (fatigue) had resolved. At the time of the report, PAIN (ache neck and scull), DIZZINESS (dizziness) and VACCINATION SITE PAIN (Pain at injection site) outcome was unknown. No concomitant medication was provided. No treatment details were provided.

Other Meds:

Current Illness:

ID: 1555332
Sex: F
Age: 79
State: MD

Vax Date: 02/16/2021
Onset Date: 02/17/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: black and blue mark at the injection site/The mark is about a 2 inch diameter; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (black and blue mark at the injection site/The mark is about a 2 inch diameter) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. Concomitant products included BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE (NEOSPORIN [BACITRACIN ZINC;NEOMYCIN SULFATE;POLYMYXIN B SULFATE]) for an unknown indication. On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced VACCINATION SITE DISCOLOURATION (black and blue mark at the injection site/The mark is about a 2 inch diameter). At the time of the report, VACCINATION SITE DISCOLOURATION (black and blue mark at the injection site/The mark is about a 2 inch diameter) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The patient received first dose on 16-Feb-2021 at 12:00 in left arm shoulder deltoid muscle. Treatment medication was not reported.

Other Meds: NEOSPORIN [BACITRACIN ZINC;NEOMYCIN SULFATE;POLYMYXIN B SULFATE]

Current Illness:

ID: 1555333
Sex: F
Age: 49
State: AZ

Vax Date: 02/05/2021
Onset Date: 02/05/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever; Chills; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Tiredness) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Tiredness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Tiredness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. concomitant medications were not reported. Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Significant TCR report received, Reporter's email address added.

Other Meds:

Current Illness:

ID: 1555334
Sex: F
Age: 72
State: PA

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: dizzy/woozy; nausea; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (sore arm), DIZZINESS (dizzy/woozy) and NAUSEA (nausea) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. No Medical History information was reported. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced PAIN (sore arm). On 02-Feb-2021, the patient experienced DIZZINESS (dizzy/woozy) and NAUSEA (nausea). On 21-Jan-2021, PAIN (sore arm) had resolved. At the time of the report, DIZZINESS (dizzy/woozy) and NAUSEA (nausea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: TCR on 25-MAY-2021 and does not contain any new information

Other Meds:

Current Illness:

ID: 1555335
Sex: F
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Nausea; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NAUSEA (Nausea). At the time of the report, NAUSEA (Nausea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. concomitant medication was not reported. Treatment medication was not reported.

Other Meds:

Current Illness:

ID: 1555336
Sex: F
Age: 83
State: RI

Vax Date: 02/22/2021
Onset Date: 02/22/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: seemed confused; difficulty speaking; little achiness; tired; no sound normal; little sore at the injection site; This spontaneous case was reported by a health care professional and describes the occurrence of FEELING ABNORMAL (no sound normal), CONFUSIONAL STATE (seemed confused), SPEECH DISORDER (difficulty speaking), PAIN (little achiness) and FATIGUE (tired) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Hypertension. Concomitant products included Levotyrixine and ATORVASTATIN for an unknown indication. On 22-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced VACCINATION SITE PAIN (little sore at the injection site). On 23-Feb-2021, the patient experienced FEELING ABNORMAL (no sound normal), PAIN (little achiness) and FATIGUE (tired). On an unknown date, the patient experienced CONFUSIONAL STATE (seemed confused) and SPEECH DISORDER (difficulty speaking). At the time of the report, FEELING ABNORMAL (no sound normal), CONFUSIONAL STATE (seemed confused), SPEECH DISORDER (difficulty speaking), PAIN (little achiness), FATIGUE (tired) and VACCINATION SITE PAIN (little sore at the injection site) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was provided. No treatment details were provided.

Other Meds: Levotyrixine; ATORVASTATIN

Current Illness: Hypertension

ID: 1555337
Sex: F
Age: 28
State: VA

Vax Date: 01/19/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Can not extend arm fully; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (Can not extend arm fully) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Injury NOS (arm had screws). On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Can not extend arm fully). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (Can not extend arm fully) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not reported. Treatment medication was not reported. The vaccination was taken on the arm that had screws in due to a previous injury.

Other Meds:

Current Illness:

ID: 1555338
Sex: M
Age:
State: NY

Vax Date: 02/06/2021
Onset Date: 02/07/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever / temperature was 101.1; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever / temperature was 101.1) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. No Medical History information was reported. On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced PYREXIA (Fever / temperature was 101.1). At the time of the report, PYREXIA (Fever / temperature was 101.1) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Feb-2021, Body temperature: 101.1 (High) 101.1. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not reported. Treatment was not taken; enquired about treatment options.

Other Meds:

Current Illness:

ID: 1555339
Sex: M
Age: 94
State: CA

Vax Date: 01/26/2021
Onset Date: 02/24/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: violent diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (violent diarrhea) in a 94-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 1042120A) for COVID-19 vaccination. No Medical History information was reported. On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Feb-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DIARRHOEA (violent diarrhea). At the time of the report, DIARRHOEA (violent diarrhea) had resolved. The patient had loose stool for about 3 to 4 times.No concomitant medications reported. No treatment medications provided by the reporter. Action taken with mRNA-1273 in response to event was not applicable. Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Follow-up information received on 21 Jun 2021.Updated outcome of event from unknown to resolved.

Other Meds:

Current Illness:

ID: 1555340
Sex: F
Age: 81
State: VA

Vax Date: 01/29/2021
Onset Date: 01/30/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: (arm) hot; arm very very red; (arm) itching; headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH ((arm) hot), VACCINATION SITE ERYTHEMA (arm very very red), VACCINATION SITE PRURITUS ((arm) itching) and HEADACHE (headache) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced HEADACHE (headache). On 07-Feb-2021, the patient experienced VACCINATION SITE WARMTH ((arm) hot), VACCINATION SITE ERYTHEMA (arm very very red) and VACCINATION SITE PRURITUS ((arm) itching). At the time of the report, VACCINATION SITE WARMTH ((arm) hot), VACCINATION SITE ERYTHEMA (arm very very red), VACCINATION SITE PRURITUS ((arm) itching) and HEADACHE (headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant information was provided No treatment information was provided; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1555341
Sex: F
Age: 42
State: SC

Vax Date: 01/25/2021
Onset Date: 01/25/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: itching sensation- all over body; my face felt numb; redness - of the face; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching sensation- all over body), HYPOAESTHESIA (my face felt numb) and ERYTHEMA (redness - of the face) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. No Medical History information was reported. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced PRURITUS (itching sensation- all over body), HYPOAESTHESIA (my face felt numb) and ERYTHEMA (redness - of the face). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itching all over, Numbness facial and Redness of face, at a dose of UNK dosage form. On 27-Jan-2021, PRURITUS (itching sensation- all over body), HYPOAESTHESIA (my face felt numb) and ERYTHEMA (redness - of the face) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not reported. Treatment included Benadryl to alleviate the symptoms and symptoms seemed to go away by 27-Jan-2021. Most recent FOLLOW-UP information incorporated above includes: On 01-Feb-2021: Reporter details, patient details, suspect product batch number, event verbatim updated.

Other Meds:

Current Illness:

ID: 1555342
Sex: F
Age: 69
State: MN

Vax Date: 02/14/2021
Onset Date: 02/21/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Red rash at injection site; Red rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Red rash at injection site) and VACCINATION SITE ERYTHEMA (Red rash at injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. No Medical History information was reported. On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced VACCINATION SITE RASH (Red rash at injection site) and VACCINATION SITE ERYTHEMA (Red rash at injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Vaccination site rash and Vaccination site erythema, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE RASH (Red rash at injection site) and VACCINATION SITE ERYTHEMA (Red rash at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not reported.

Other Meds:

Current Illness:

ID: 1555343
Sex: M
Age:
State: IL

Vax Date: 02/09/2021
Onset Date: 02/22/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: was itchy; rash at injection sight; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash at injection sight) and VACCINATION SITE PRURITUS (was itchy) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination. No Medical History information was reported. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced VACCINATION SITE RASH (rash at injection sight) and VACCINATION SITE PRURITUS (was itchy). The patient was treated with HYDROCORTISONE for Vaccination site pruritus, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE RASH (rash at injection sight) and VACCINATION SITE PRURITUS (was itchy) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported . At the time of report, rash was bigger. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1555344
Sex: M
Age:
State: IL

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 031M20A) for COVID-19 vaccination. No Medical History information was reported. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown. No concomitant medications reported. No treatment medications provided by the reporter. Action taken with mRNA-1273 in response to event was not applicable. This case was linked to MOD-2021-024115 (Patient Link).

Other Meds:

Current Illness:

ID: 1555345
Sex: F
Age:
State: KY

Vax Date: 02/05/2021
Onset Date: 02/05/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: had difficulty breathing; Raised area at injection site; Redness at injection site; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (had difficulty breathing), VACCINATION SITE SWELLING (Raised area at injection site), VACCINATION SITE PRURITUS (Redness at injection site) and VACCINATION SITE PAIN (Pain at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported). On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced DYSPNOEA (had difficulty breathing), VACCINATION SITE SWELLING (Raised area at injection site), VACCINATION SITE PRURITUS (Redness at injection site) and VACCINATION SITE PAIN (Pain at injection site). At the time of the report, DYSPNOEA (had difficulty breathing), VACCINATION SITE SWELLING (Raised area at injection site), VACCINATION SITE PRURITUS (Redness at injection site) and VACCINATION SITE PAIN (Pain at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment details included unknown. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1555346
Sex: F
Age: 67
State:

Vax Date: 01/30/2021
Onset Date: 02/01/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: numbness on the right arm where she was vaccinated; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HYPOAESTHESIA (numbness on the right arm where she was vaccinated) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. No Medical History information was reported. On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced VACCINATION SITE HYPOAESTHESIA (numbness on the right arm where she was vaccinated). The patient was treated with FUROSEMIDE (LASIX [FUROSEMIDE]) on 01-Feb-2021 for Vaccination site hypoaesthesia, at a dose of UNK dosage form. On 01-Feb-2021, VACCINATION SITE HYPOAESTHESIA (numbness on the right arm where she was vaccinated) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not reported. Treatment medication was reported as Lasix.

Other Meds:

Current Illness:

ID: 1555347
Sex: F
Age: 75
State: NC

Vax Date: 02/11/2021
Onset Date: 02/14/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: arm swelled up; arm turned red; arm was hot; arm itched on and off; Injection site still 3-4-inch mark; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm swelled up), ERYTHEMA (arm turned red), SKIN WARM (arm was hot), PRURITUS (arm itched on and off) and VACCINATION SITE RASH (Injection site still 3-4-inch mark) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. Concurrent medical conditions included High cholesterol, Penicillin allergy, Drug allergy (atorvastatin, cefdinir, diclofenac, meloxicam, zoster vaccine, amoxicillin, Biaxin, codeine, penicillin, Levaquin, levofloxacin, doxycycline, nitrofurantoin and carisoprodol), Allergy to antibiotic and Allergy to vaccine. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced PERIPHERAL SWELLING (arm swelled up), ERYTHEMA (arm turned red), SKIN WARM (arm was hot), PRURITUS (arm itched on and off) and VACCINATION SITE RASH (Injection site still 3-4-inch mark). At the time of the report, PERIPHERAL SWELLING (arm swelled up), ERYTHEMA (arm turned red), SKIN WARM (arm was hot), PRURITUS (arm itched on and off) and VACCINATION SITE RASH (Injection site still 3-4-inch mark) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not reported. Treatment medication was not reported.

Other Meds:

Current Illness: Allergy to antibiotic; Allergy to vaccine; Drug allergy (atorvastatin, cefdinir, diclofenac, meloxicam, zoster vaccine, amoxicillin, Biaxin, codeine, penicillin, Levaquin, levofloxacin, doxycycline, nitrofurantoin and carisoprodol); High cholesterol; Penicillin allergy

ID: 1555348
Sex: F
Age:
State: FL

Vax Date: 02/06/2021
Onset Date: 02/07/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Migraine; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine) and NAUSEA (Nausea) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012620A) for COVID-19 vaccination. No Medical History information was reported. On 06-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced MIGRAINE (Migraine) and NAUSEA (Nausea). At the time of the report, MIGRAINE (Migraine) and NAUSEA (Nausea) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1555349
Sex: F
Age: 66
State:

Vax Date: 01/19/2021
Onset Date: 02/17/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pressure in the head; Headache; Any change in the body elevation makes the headache worse; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Feb-2021 and was forwarded to Moderna on 24-Feb-2021. This spontaneous case was reported by a nurse and describes the occurrence of HEAD DISCOMFORT (Pressure in the head), HEADACHE (Headache) and HEADACHE (Any change in the body elevation makes the headache worse) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043L20A and 011320A) for COVID-19 vaccination. Concurrent medical conditions included Pre-diabetes. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced HEAD DISCOMFORT (Pressure in the head), HEADACHE (Headache) and HEADACHE (Any change in the body elevation makes the headache worse). At the time of the report, HEAD DISCOMFORT (Pressure in the head), HEADACHE (Headache) and HEADACHE (Any change in the body elevation makes the headache worse) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment information was provided.Concomitant medication includes pre diabetes medication

Other Meds:

Current Illness: Pre-diabetes

ID: 1555350
Sex: F
Age: 51
State: GA

Vax Date: 01/12/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Petechiae; blister with blood underneath behind her knee; bruiseon abdomen and right arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 25-Feb-2021 and was forwarded to Moderna on 26-Feb-2021. This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of PETECHIAE (Petechiae), BLISTER (blister with blood underneath behind her knee) and CONTUSION (bruiseon abdomen and right arm) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20a and 012l20a) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PETECHIAE (Petechiae), BLISTER (blister with blood underneath behind her knee) and CONTUSION (bruiseon abdomen and right arm). At the time of the report, PETECHIAE (Petechiae), BLISTER (blister with blood underneath behind her knee) and CONTUSION (bruiseon abdomen and right arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication was not provided. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1555351
Sex: F
Age: 62
State: MA

Vax Date: 02/04/2021
Onset Date: 02/04/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Body ache; Aches in the leg; Aches in the arm; Headache; Fatigue; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body ache), PAIN IN EXTREMITY (Aches in the leg), PAIN IN EXTREMITY (Aches in the arm), HEADACHE (Headache) and FATIGUE (Fatigue) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 04-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PAIN (Body ache), PAIN IN EXTREMITY (Aches in the leg), PAIN IN EXTREMITY (Aches in the arm), HEADACHE (Headache), FATIGUE (Fatigue) and NAUSEA (Nausea). At the time of the report, PAIN (Body ache), PAIN IN EXTREMITY (Aches in the leg), PAIN IN EXTREMITY (Aches in the arm), HEADACHE (Headache), FATIGUE (Fatigue) and NAUSEA (Nausea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient is taking other medication. No treatment information was provided. No relevant concomitant medications reported.

Other Meds:

Current Illness:

ID: 1555352
Sex: F
Age:
State: IL

Vax Date:
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: disorientated; This spontaneous case was reported by a consumer and describes the occurrence of DISORIENTATION (disorientated) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided. Previously administered products included for an unreported indication: ASPIRIN (E.C.). On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DISORIENTATION (disorientated). At the time of the report, DISORIENTATION (disorientated) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment information was provided. Concomitant information was not provided. Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Additional information include no new information.

Other Meds:

Current Illness:

ID: 1555353
Sex: M
Age: 92
State: NY

Vax Date: 02/17/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: cough; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Feb-2021 and was forwarded to Moderna on 24-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COUGH (cough). At the time of the report, COUGH (cough) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information was not provided. Concomitant information was not provided. This case was linked to MOD-2021-024260 (E2B Linked Report).; Sender's Comments: MOD-2021-024260:same reporter, different patient and event

Other Meds:

Current Illness:

ID: 1555354
Sex: F
Age:
State: FL

Vax Date: 01/23/2021
Onset Date: 02/24/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: both arms are numb - feels like they have gone to sleep; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (both arms are numb - feels like they have gone to sleep) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. Concomitant products included INSULIN DETEMIR (LEVEMIR), INSULIN ASPART (NOVOLOG), RAMIPRIL, CARVEDILOL, CELECOXIB (CELEBREX), ESTROGENS CONJUGATED (PREMARIN), AMITRIPTYLINE, OMEPRAZOLE (PROTONIX [OMEPRAZOLE]), POTASSIUM CHLORIDE, ACETYLSALICYLIC ACID (BABY ASPIRIN), LEVOTHYROXINE SODIUM (SYNTHROID), DULOXETINE HYDROCHLORIDE (CYMBALTA), ATORVASTATIN CALCIUM (LIPITOR), DICYCLOMINE HCL, HYDROCHLOROTHIAZIDE, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and METFORMIN for an unknown indication. On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced HYPOAESTHESIA (both arms are numb - feels like they have gone to sleep). At the time of the report, HYPOAESTHESIA (both arms are numb - feels like they have gone to sleep) outcome was unknown. Possible No treatment medications were reported. Action taken with mRNA-1273 in response to the events was not Applicable.

Other Meds: LEVEMIR; NOVOLOG; RAMIPRIL; CARVEDILOL; CELEBREX; PREMARIN; AMITRIPTYLINE; PROTONIX [OMEPRAZOLE]; POTASSIUM CHLORIDE; BABY ASPIRIN; SYNTHROID; CYMBALTA; LIPITOR; DICYCLOMINE HCL; HYDROCHLOROTHIAZIDE; VITAMIN D 2000; METFORMIN

Current Illness:

ID: 1555355
Sex: M
Age: 76
State: CA

Vax Date: 01/27/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: feel lousy/feeling worse/I don't feel good physically; feeling psychotic; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Feb-2021 and was forwarded to Moderna on 24-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feel lousy/feeling worse/I don't feel good physically) and PSYCHOTIC DISORDER (feeling psychotic) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (feel lousy/feeling worse/I don't feel good physically) and PSYCHOTIC DISORDER (feeling psychotic). At the time of the report, MALAISE (feel lousy/feeling worse/I don't feel good physically) outcome was unknown and PSYCHOTIC DISORDER (feeling psychotic) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information was not provided. concomitant information was not provided.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 599,999

Page last modified: 03 October 2021 5:28pm